Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells

Journal of Viral Hepatitis

Volumn 19, Issue 2, 2012, Pages

  Shi, C C ^a,b   Tjwa, E T T L ^b   Biesta, P J ^b   Boonstra, A ^b   Xie, Q ^a   Janssen, H L A ^b   Woltman, A M ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

cell interaction; hepatitis B virus; interferon ; natural killer cell; plasmacytoid dendritic cell

Indexed keywords

CD69 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ARTICLE; CELL ACTIVATION; CELL COUNT; CELL FUNCTION; CELL INTERACTION; CELL STRAIN HEPG2; CLINICAL ARTICLE; COCULTURE; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOASSAY; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PERSISTENT VIRUS INFECTION; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL;

CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; HEPATITIS B VIRUS; HUMANS; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION;

EID: 84855853240     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01496.x     Document Type: Article

References (26)

1. Wieland SF, Spangenberg HC, Thimme R, Purcell RH, Chisari FV,. Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proc Natl Acad Sci U S A 2004; 101 (7): 2129-2134. (Pubitemid 38229026)
2. van der Molen RG, Sprengers D, Binda RS, et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 2004; 40 (3): 738-746. (Pubitemid 39265597)
3. Woltman AM, Boonstra A, Janssen HL,. Dendritic cells in chronic viral hepatitis B and C: victims or guardian angels? Gut 2010; 59 (1): 115-125.
4. Rehermann B, Nascimbeni M,. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5 (3): 215-229. (Pubitemid 40364823)
5. Karimi K, Blois SM, Arck PC,. The upside of natural killers. Nat Med 2008; 14 (11): 1184-1185.
6. Martin-Fontecha A, Thomsen LL, Brett S, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004; 5 (12): 1260-1265. (Pubitemid 41057741)
7. Cooper MA, Fehniger TA, Caligiuri MA,. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22 (11): 633-640. (Pubitemid 33043908)
8. Raulet DH,. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 2004; 5 (10): 996-1002. (Pubitemid 41057716)
9. Fernandez NC, Lozier A, Flament C, et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1999; 5 (4): 405-411. (Pubitemid 29180578)
10. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G,. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002; 195 (3): 327-333. (Pubitemid 34461490)
11. Colonna M, Trinchieri G, Liu YJ,. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004; 5 (12): 1219-1226. (Pubitemid 41057736)
12. Della Chiesa M, Sivori S, Castriconi R, Marcenaro E, Moretta A,. Pathogen-induced private conversations between natural killer and dendritic cells. Trends Microbiol 2005; 13 (3): 128-136. (Pubitemid 40311895)
13. Persson CM, Chambers BJ,. Plasmacytoid dendritic cell-induced migration and activation of NK cells in vivo. Eur J Immunol 2010; 40 (8): 2155-2164.
14. Tjwa ET, van Oord GW, Hegmans JP, Janssen HL, Woltman AM,. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J Hepatol 2011; 54 (2): 209-218.
15. Oliviero B, Varchetta S, Paudice E, et al. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 2009; 137 (3): 1151-1160.
16. Peppa D, Micco L, Javaid A, et al. Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog 2010; 6 (12): e1001227.
17. Woltman AM, Op den Brouw ML, Biesta PJ, Shi CC, Janssen HL,. Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function. PLoS ONE 2011; 6 (1): e15324.
18. Xie Q, Shen HC, Jia NN, et al. Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9. Microbes Infect 2009; 11 (4): 515-523.
19. Duan XZ, Wang M, Li HW, Zhuang H, Xu D, Wang FS,. Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. J Clin Immunol 2004; 24 (6): 637-646. (Pubitemid 40933115)
20. Untergasser A, Zedler U, Langenkamp A, et al. Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection. Hepatology 2006; 43 (3): 539-547.
21. Lanier LL,. NK cell recognition. Annu Rev Immunol 2005; 23: 225-274. (Pubitemid 40563170)
22. Romagnani C, Della Chiesa M, Kohler S, et al. Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells. Eur J Immunol 2005; 35 (8): 2452-2458. (Pubitemid 41179766)
23. Xu Y, Hu Y, Shi B, et al. HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. Mol Immunol 2009; 46: 2640-2646.
24. Conry SJ, Milkovich KA, Yonkers NL, et al. Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function. J Virol 2009; 83 (21): 11175-11187.
25. Reitano KN, Kottilil S, Gille CM, et al. Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection. AIDS Res Hum Retroviruses 2009; 25 (10): 1029-1037.
26. Hong HS, Bhatnagar N, Ballmaier M, et al. Exogenous HIV-1 Vpr disrupts IFN-alpha response by plasmacytoid dendritic cells (pDCs) and subsequent pDC/NK interplay. Immunol Lett 2009; 125: 100-104.